Tilray Brands Inc. closed 80.73% short of its 52-week high of $2.15, which the company achieved on July 30th.

According to Benzinga Pro, TLRY stock has lost over 76% in the past year. In a separate release, Montauk Brewing Co., a ...

The stock's fall snapped a four-day winning streak.

Tilray Brands, Inc. (TLRY) closed the most recent trading day at $0.40, moving -2.84% from the previous trading session. The stock fell short of the S&P 500, which registered a gain of 0.52% for the ...

As traditional cannabis and alcohol sales slow, the company is marketing beverages with low THC as a way to help consumers ...

Tilray Brands (NasdaqGS:TLRY) has recently published a scientific study through its medical division, comparing the bioavailability of different cannabinoid formulations. This event, paired with the ...

Through its wholly-owned subsidiary, FL Group, Tilray has become the first company in Italy to receive official authorization ...

A trial court correctly interpreted 2023 Delaware corporate law amendments that lowered certain voting standards when ...

Tilray Medical, a division of Tilray Brands (TSX:TLRY), has become the first company to receive Italian authorization to ...

Tilray Medical, a division of Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients ...

Aurora Cannabis sees growth with high-margin medical cannabis, debt cuts, and EBITDA gains. Click here to read an analysis of ACB stock now.

Tilray also operates a pharmaceutical distribution business in Europe, which delivers its medical cannabis as well as other medications to pharmacies and is responsible for 33% of its revenue.